An augmented migratory potential was reported for a large number of ACTN4-over-expressing cells, including osteosarcoma, colorectal cancer, squamous carcinoma, breast cancer, lung cancer, and others [2,11,17,21,23,35,63,71,93,94]. This evidence concerns the gene ACTN4 and breast carcinoma.